Janus Henderson Capital Funds plc - Global Life Sciences Fund Class H2 GBP

Register to Unlock Ratings
Performance History31/03/2024
Growth of 1,000 (GBP) Advanced Graph
Janus Henderson Capital Funds plc - Global Life Sciences Fund Class H2 GBP
Fund21.37.48.71.59.6
+/-Cat3.8-2.013.44.64.3
+/-B’mrk--10.82.94.11.5
 
Key Stats
NAV
17/04/2024
 GBP 57.48
Day Change -0.38%
Morningstar Category™ Sector Equity Healthcare
IA (formerly IMA) Sector -
ISIN IE00B8GQ0T69
Fund Size (Mil)
17/04/2024
 USD 3814.22
Share Class Size (Mil)
17/04/2024
 GBP 17.34
Max Initial Charge -
Ongoing Charge
20/03/2024
  0.86%
Investment Objective: Janus Henderson Capital Funds plc - Global Life Sciences Fund Class H2 GBP
The Fund’s investment objective is long-term growth of capital. It pursues its objective by investing at least 80% of its net asset value in equities (also known as company shares) located anywhere in the world and selected for their growth potential. The Fund will invest at least 80% of its net asset value in companies that the relevant Sub-Investment Adviser believes have a life sciences orientation. Generally speaking, the “life sciences” relate to maintaining or improving quality of life. Thus, companies with a “life sciences orientation” include companies engaged in research, development, production or distribution of products or services related to health and personal care, medicine or pharmaceuticals. Such companies may also include companies that the relevant Sub-Investment Adviser believes have growth potential mainly as a result of particular products, technology, patents or other market advantages in the life sciences.
Returns
Trailing Returns (GBP)17/04/2024
YTD4.13
3 Years Annualised8.17
5 Years Annualised12.23
10 Years Annualised14.49
12 Month Yield 0.00
Management
Manager Name
Start Date
Andy Acker
01/05/2007
Daniel Lyons
31/01/2023
Inception Date
02/01/2013
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
MSCI World/Health Care NR USDMorningstar Gbl Health TME NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Janus Henderson Capital Funds plc - Global Life Sciences Fund Class H2 GBP31/03/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock97.670.0097.67
Bond0.000.000.00
Property0.000.000.00
Cash0.880.000.88
Other1.460.001.46
Top 5 Regions%
United States80.90
Europe - ex Euro10.07
United Kingdom3.68
Eurozone2.81
Japan1.60
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Eli Lilly and CoHealthcareHealthcare7.04
UnitedHealth Group IncHealthcareHealthcare5.84
Novo Nordisk A/S5.12
Merck & Co IncHealthcareHealthcare3.62
AstraZeneca PLCHealthcareHealthcare3.59
Janus Henderson Capital Funds plc - Global Life Sciences Fund Class H2 GBP

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures